Convertibles Calendar: Enovis on deck

Oct. 19

ENOVIS CORP.

• $400 million five-year convertible notes

• $60 million greenshoe

• Coupon of 3.625% to 4.125% and initial conversion premium of 27.5% to 32.5%

• Non-callable

• Special redemption at 101 plus accrued interest if the company’s acquisition of LimaCorporate SpA is not consummated by June 30, 2024

• Rule 144A

• J.P. Morgan Securities LLC and UBS Securities LLC

• Proceeds to fund the cost of the call spread, repurchase a portion of its 1.25% convertible notes due 2025 for cash, and general corporate purposes, which may include acquisitions and strategic transactions to cover the call spread with the remaining amount, together with borrowings under a new term loan and cash on hand, to be used to fund the cash purchase price of the acquisition of LimaCorporate

• Wilmington, Del.-based medical technology company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.